You searched for Brain.
337 results
Oncology Clinical Trial: Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
Clinical Trial Protocol # ACNS02B3 | Biology/Genomics, Brain Tumor/Central Nervous System/Neuro-Oncology | Contact (714) 509-8646
Clowns do more than lift spirits at children’s hospitals, they change brains
With medical clown visits, it's not just about children. Spreading happiness is good for adults as well, especially parents struggling with a child in the hospital.
Brain and Spine Tumors Program
The pediatric Brain and Spine Tumors Program at the Hyundai Cancer Institute at CHOC is a team of highly trained, multidisciplinary neuro-oncology specialists.
Deep Brain Stimulation (DBS) Surgery in Children
What is Deep Brain Stimulation Surgery? Learn about DBS Surgery for children: how it works, risks, side effects, and more.
Brain Tumors in Children
Brain tumors in children can be complex. At CHOC, a multidisciplinary approach offers all services our patients need under one roof.
Traumatic Brain Injury (TBI)
Traumatic brain injury (TBI) is sudden damage to the brain caused by an external force. Visit our page to learn about symptoms, diagnosis, treatment, and more.
Arachnoid Cysts and Other Brain Cysts
Most arachnoid cysts can be monitored with no intervention, but if they grow too large, treatment becomes necessary. Read more here.
When a Child Has a Brain Tumor
Dr. William Loudon discusses the symptoms of brain tumors in children and the innovative and minimally invasive ways CHOC is treating them.
Is it a Brain Tumor? Dr. Taraman
Dr. Sharief Taraman, CHOC, tells us what type of condition could mimic a brain tumor and what are the syptoms that patients can experience.
When a Child has a Low-Grade Glioma (Brain Tumor)
Dr. Ashley Plant, pediatric oncologist, discusses what a low-grade glioma, also known as a brain tumor, is and how it’s treated.
Oncology Clinical Trial: WEE1 Inhibitor MK-1775 and Local Radiation Therapy in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
Clinical Trial Protocol # ADVL1217 | Brain Tumor/Central Nervous System/Neuro-Oncology | Contact (714) 509-8646
ADVL1615, A Phase 1 Study of Pevonedistat (MLN4924, IND# 136078), a NEDD8 Activating Enzyme (NAE) Inhibitor, in Combination with Temozolomide and Irinotecan in Pediatric Patients with Recurrent or Refractory Solid Tumors
Clinical Trial Protocol # ADVL1615 | Adolescents and Young Adults, Brain Tumor/Central Nervous System/Neuro-Oncology, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
ACNS1422 A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
Clinical Trial Protocol # ACNS1422 | Brain Tumor/Central Nervous System/Neuro-Oncology | Contact (714) 509-8646
Oncology Clinical Trial: WEE1 Inhibitor MK-1775 and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Clinical Trial Protocol # ADVL1312 | Adolescents and Young Adults, Brain Tumor/Central Nervous System/Neuro-Oncology, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
AHOD1721/BMS CA209744 – Risk-based, response-adapted, Phase II open-label trial of nivolumab + brentuximab vedotin (N + Bv) for children, adolescents, and young adults with relapsed/refractory (R/R) CD30 + classic Hodgkin lymphoma (cHL) after
Clinical Trial Protocol # AHOD1721 | Adolescents and Young Adults, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
Clinical Trial Protocol # ACNS0831 | Brain Tumor/Central Nervous System/Neuro-Oncology | Contact (714) 509-8646
Oncology Clinical Trial: Molecular Profiles of Refractory and Recurrent Childhood, Adolescent, and Young Adult Cancers
Clinical Trial | Adolescents and Young Adults, Biology/Genomics, Brain Tumor/Central Nervous System/Neuro-Oncology, Leukemia/Lymphoma, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
Clinical Trial Protocol # ACNS0331 | Brain Tumor/Central Nervous System/Neuro-Oncology | Contact (714) 509-8646
Oncology Clinical Trial: A Study to Determine Safety, Tolerability and Pharmacokinetics of Oral Dabrafenib In Children and Adolescent Subjects
Clinical Trial | Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors
Clinical Trial Protocol # ADVL1416 | Brain Tumor/Central Nervous System/Neuro-Oncology, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
ADVL1513, A Phase 1 Study of Entinostat, an Oral Histone Deacetylase Inhibitor, in Pediatric Patients with Recurrent or Refractory Solid Tumors, including CNS Tumors and Lymphoma
Clinical Trial Protocol # ADVL1513 | Adolescents and Young Adults, Brain Tumor/Central Nervous System/Neuro-Oncology, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
ADVL1515 A Phase 1 Study of LY2606368, a CHK1/2 Inhibitor, in Pediatric Patients with Recurrent or Refractory Solid Tumors, including CNS Tumors
Clinical Trial Protocol # ADVL1515 | Adolescents and Young Adults, Brain Tumor/Central Nervous System/Neuro-Oncology, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors
Clinical Trial Protocol # Head Start IV | Brain Tumor/Central Nervous System/Neuro-Oncology | Contact (714) 509-8646
Oncology Clinical Trial: Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma
Clinical Trial Protocol # ACNS0332 | Brain Tumor/Central Nervous System/Neuro-Oncology | Contact (714) 509-8646